Clinical Research Consortium

Las Vegas, Nevada 89119-5190

0 studies enrolling now · 26 studies all time

What they study most

Arthritis, Asthma, Atopic Dermatitis, COPD, Chronic Pain, Depressive Disorder, Major, Diabetic Nephropathies, Diabetic Neuropathy, Painful, Diabetic Peripheral Neuropathy, Healthy Normal Volunteers, Low Back Pain, Major Depressive Disorder

Studies at this site

• A Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy — Completed
• Biomarkers of Exposure and Biomarkers of Potential Harm in Adult Smokers Who Completely Switch to E-vapor Products — Completed
• A Phase III Trial of e-TNS for the Acute Treatment of Migraine — Completed
• A Phase 3 Efficacy and Safety Study of Intra-articular CNTX-4975-05 (Capsaicin) vs Placebo in Subjects With OA Knee Pain — Completed
• JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic Dermatitis — Completed
• A Study of Tanezumab in Adults With Chronic Low Back Pain — Completed
• SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension Study — Stopped early
• SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder — Completed
• Study to Evaluate the Safety, Tolerability, and PK of Fulvestrant After IM Administration — Completed
• Tanezumab in Osteoarthritis of the Hip or Knee (2) — Completed
• Tanezumab In Osteoarthritis Of The Knee (2) — Completed
• Extension Study Of Tanezumab In Osteoarthritis — Stopped early
• Long Term Safety Study of Tanezumab in Chronic Low Back Pain — Stopped early
• Tanezumab in Osteoarthritis of the Knee — Completed
• A Study to Examine the Safety and Efficacy of a New Drug in Patients With Symptoms of Overactive Bladder (OAB) — Completed
• Tanezumab in Osteoarthritis Of The Hip — Completed
• Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain — Completed
• Efficacy and Safety Study of Pregabalin in the Treatment of Pain on Walking in Patients With Diabetic Peripheral Neuropathy (DPN) — Completed
• A Safety and Tolerability Study of UBX0101 in Patients With Osteoarthritis of the Knee — Completed
• Long Term Safety and Efficacy Study of Tanezumab in Subjects With Osteoarthritis of the Hip or Knee — Completed
• Study To Evaluate Pf-04965842 In Subjects With Moderate To Severe Atopic Dermatitis — Completed
• A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy — Completed
• Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD — Completed
• A Study of Lebrikizumab in Participants With Uncontrolled Asthma on Inhaled Corticosteroids and a Second Controller Medication — Completed
• A Clinical Trial To Evaluate PF-05089771 On Its Own And As An Add-On Therapy To Pregabalin (Lyrica) For The Treatment Of Pain Due To Diabetic Peripheral Neuropathy (DPN) — Completed
• A Normal Donor Sample Collection Study in Healthy Adults — Completed